Clinical Trial Update: A Phase 2 Trial of MLN8237 in Adult Participants With Acute Myelogenous Leukemia and High-Grade Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update on MLN8237 (alisertib) in adults with acute myeloid leukemia and high-grade myelodysplastic syndrome; the study is completed and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• High-grade Myelodysplastic Syndrome

Drugs mentioned

• Alisertib (alisertib)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Acute Myelogenous Leukemia, High-Grade Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2018-05-11